Episode 074 | Regenexx: Joint Restoration
McGohan Brabender Side Affects: Disrupting Health Care - A podcast by Employee Benefits | Health Care | Wellness | Leadership | Health Management | Innovation | Human Resources | Employee Engagement | Consumerism | Business | McGohan Brabender | Side Affects | Side Effects - Wednesdays
Categories:
Take a listen to this special Side Affects episode with Scott McGohan and MB President, Mike Suttman as they chat with Regenexx CEO, Jason Hellickson to learn more about an increasingly popular alternative versus orthopedic surgeries, if possible. Regenexx uses human healing cells as agents to restore compromised joints. Regenexx research is based on outcomes for a very fluid approach to the healing process. Tune in to learn how assumed procedures are being replaced by a less evasive process both physically and financially.
